Evidence map›Paper›PMID 27356471›Full record

ArticleScientific reports2016

Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes.

Emilia Galli, Taina Härkönen, Markus T Sainio, Mart Ustav, Urve Toots, Arto Urtti, Marjo Yliperttula, Maria Lindahl, Mikael Knip, Mart Saarma and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Dual role of neuroplastin in pancreatic β cells: Regulating insulin secretion and promoting islet inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. UPR Responsive GenesFrontiers in cellular neuroscience · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. A soluble endoplasmic reticulum factor as regenerative therapy for Wolfram syndrome.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Emilia GalliInstitute of Biotechnology, University of Helsinki, Finland.
Taina HärkönenChildren's Hospital, University of Helsinki and Helsinki University Central Hospital, Finland.
Markus T SainioInstitute of Biotechnology, University of Helsinki, Finland.
Mart UstavIcosagen Ltd., Tartu, Estonia.
Urve TootsIcosagen Ltd., Tartu, Estonia.
Arto UrttiDivision of Pharmaceutical Biosciences, Centre for Drug Research, University of Helsinki, Finland.
Marjo YliperttulaDivision of Pharmaceutical Biosciences, Centre for Drug Research, University of Helsinki, Finland.
Maria LindahlInstitute of Biotechnology, University of Helsinki, Finland.
Mikael KnipChildren's Hospital, University of Helsinki and Helsinki University Central Hospital, Finland.
Mart SaarmaInstitute of Biotechnology, University of Helsinki, Finland.
Päivi LindholmInstitute of Biotechnology, University of Helsinki, Finland.
University of Helsinki · FIIcosagen (Estonia) · EEFolkhälsans Forskningscentrum · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesencephalic astrocyte-derived neurotrophic factor (MANF) was recently shown to be essential for the survival and proliferation of pancreatic β-cells in mice, where deletion of MANF resulted in diabetes. The current study aimed at determining whether the concentration of circulating MANF is associated with the clinical manifestation of human type 1 diabetes (T1D). MANF expression in T1D or MANF levels in serum have not been previously studied. We developed an enzyme-linked immunosorbent assay (ELISA) for MANF and measured serum MANF concentrations from 186 newly diagnosed children and adolescents and 20 adults with longer-term T1D alongside with age-matched controls. In healthy controls the mean serum MANF concentration was 7.0 ng/ml. High MANF concentrations were found in children 1-9 years of age close to the diagnosis of T1D. The increased MANF concentrations were not associated with diabetes-predictive autoantibodies and autoantibodies against MANF were extremely rare. Patients with conspicuously high MANF serum concentrations had lower C-peptide levels compared to patients with moderate MANF concentrations. Our data indicate that increased MANF concentrations in serum are associated with the clinical manifestation of T1D in children, but the exact mechanism behind the increase remains elusive.

Indexed as

AdultAutoantibodiesChildChild, PreschoolC-PeptideDiabetes Mellitus, Type 1Enzyme-Linked Immunosorbent AssayFemaleGene Expression RegulationHumansInfantInsulin-Secreting CellsMaleNerve Growth FactorsNeuronsAutoantibodiesC-PeptideMANF protein, humanNerve Growth Factors

Identifiers

PMID27356471
PMCPMC4928177
OpenAlexW2464261561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.